The global microbiology testing market is expected to cross USD 5409.1 6 Million by 2027 at a CAGR of 10.4%. The extensively studied report covers the drivers that are going to impact the market decidedly during the forecast period and delivers a much-precise predictive analysis of the coming years of the market. Infectious diseases are on the rise, and several outbreaks of epidemics across the globe have spurred the demand for microbiology testing. Healthcare segment is witnessing a significant increase in expenditure all over the world, and an increase in research allotments are a positive sign for the microbiology testing market. Microbiology Testing Market Growth is significant during forecast period. As per Global Microbiology Testing Market Analysis , the Global Market based companies will face certain challenges during the forecast period 2020 to 2027.
However, the market can witness a slight pullback caused by stringent regulatory frameworks, and patient reimbursement policies can impede the market growth for a short span of time. But the bottlenecked market can see a wider scope of possibility with improving technologies in the field of product enhancement which can ease the market growth considerably.
Industry Trend:
The launch of Endozyme II Go by bioMerieux to test endotoxin in pharmaceutical grade water, injectable drugs, and other pharmaceutical products can be considered a remarkable step. This would also ensure easier and faster workflow than the previous models.
Becton, Dickinson, and Company (BD) has launched several diagnostic informatics and automation innovations to impact the microbiology testing market considerably. BD COR among them is an instrument to clinically measure women’s health, sexually transmitted infections and gastrointestinal applications. On the other hand, BD Kiestra ID/AST modules will use automation for bacterial identification and antibiotic susceptibility testing.
Segmentation:
The global microbiology testing market can be segmented by type, application, and end-users.
By type, the market can be segmented into instruments, chemicals reagents, rapid microbiology testing ,consumables accessories, and others. Chemicals reagents segment accounts for almost 42.1% of the global market
Application-based segmentation includes gastrointestinal infections, respiratory infections, urinary tract infections, sexually transmitted infections, and others.
Based on end-users, the market can be segmented into hospital-based laboratory, independent laboratory, and academics research institutes.
Regional Analysis:
Geographically, the market spans across regions namely North America, Europe, Asia Pacific (APAC), and the Middle East Africa (MEA).
North America with 37.9% of the global share accounts for the maximum market share. Superior infrastructure, high amount of healthcare investment and a huge patient pool suffering from infectious diseases are pushing the market ahead, and the sector is equally trying to use innovation as the championing cause for further support.
The APAC is the second largest market and the fastest one as well. The market is expecting a stellar CAGR of 12.1% to drive them forward during the forecast period. Emerging economies from the region are spending remarkably to ensure an indelible impact on the market. Europe also is waiting to record significant growth rate during the review period. However, the MEA can fall behind the global average but will ensure a steady growth pace.
Market Dashboard:
The market is quite competitive as regional players are also giving the major market influencers steep competition. Strategies that have been employed by many include new launches just the way bioMerieux did and mergers and collaborations. For instance, Abbott has recently acquired Alere. Thermo Fisher Scientific Inc. on the other hand, has signed an agreement to acquire Gatan from Roper Technologies.
Some of the prominent players in this market are Alere (US), BD (US), Beckman Coulter, Inc. (US), Biomérieux SA (France), Cepheid (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
